What's happened
The FDA has concluded a year-plus review of U.S. infant formula, testing hundreds of samples for heavy metals, pesticides, PFAS and other substances. Officials say levels are undetectable or very low, supporting continued use of available formulas amid ongoing supply concerns.
What's behind the headline?
What the findings imply
- The FDA’s testing has found contaminant levels to be undetectable or very low in most categories, reinforcing the safety profile of available infant formulas.
- External experts have endorsed the assessment, noting that trace amounts of some substances can occur naturally in the environment.
- The results may influence how parents choose among formula options, given broad availability and ongoing supply stability.
What to watch next
- Regulators may continue monitoring for new contaminants as the formula market evolves.
- Industry groups could adjust labeling or sourcing in response to any future safety signals.
- Consumers should stay informed about any updates from the FDA or independent reviews.
Implications for readers
- There is no current need to avoid available formula options based on the latest safety review.
- Ongoing monitoring will help maintain confidence in the supply chain amid past shortages.
How we got here
Operation Stork Speed, the FDA’s largest and most rigorous review of infant formula to date, has assessed more than 300 samples from 2023–2025 for contaminants and safety. Independent experts have reviewed the results, which show contaminants are below EPA drinking-water limits and most PFAS are not detected, supporting the safety of current formula options.
Our analysis
The Independent reports that the FDA’s Operation Stork Speed has tested over 300 infant formula samples between 2023 and 2025, finding contaminants to be undetectable or very low, with heavy metals below EPA drinking-water limits and most PFAS not detected. AP News corroborates the same findings. Both outlets cite outside experts, including Dr. Steven Abrams of the University of Texas at Austin, who reviewed the results. NY Post discusses EU-wide cosmetic chemical bans, providing context on regulatory approaches but not about infant formula safety. Read The Independent: FDA’s Operation Stork Speed has found infant formula to be safe with low contaminant levels; AP News confirms the conclusions. The New York Post adds a contrasting regulatory perspective from cosmetics, highlighting differing safety regimes.
Go deeper
- What specific formulas were included in the FDA’s sample set?
- Will the FDA publish a full methodology or data set for public review?
- How should parents interpret trace contaminant findings in light of ongoing environmental exposure?
More on these topics
-
Abbott Laboratories - American global health care and medical device products company
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States (13% of 2024 revenues..